Description

Co-Amlessa (perindopril tert-butylamine, indapamide, amlodipine) tablets 8 mg/2.5 mg/10 mg. №30

Ingredients:

Each tablet contains:

• Perindopril tert-butylamine 8 mg
• Indapamide 2.5 mg
• Amlodipine 10 mg

Dosage:

The recommended dose is one tablet daily, preferably taken in the morning with or without food.

Indications:

Co-Amlessa tablets are indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled on monotherapy.

Contraindications:

Do not use Co-Amlessa if you are allergic to any of the ingredients, have a history of angioedema related to previous ACE inhibitor therapy, or if you are pregnant.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Studies have shown that the combination of perindopril, indapamide, and amlodipine in Co-Amlessa tablets provides superior blood pressure control compared to individual components alone. This triple combination therapy targets different mechanisms involved in blood pressure regulation, leading to enhanced efficacy.

Additional Information:

It is important to regularly monitor blood pressure levels while taking Co-Amlessa tablets to ensure optimal control. In case of any adverse reactions or concerns, consult a healthcare professional immediately.

Co-Amlessa has been well-tolerated in clinical trials, with common side effects including dizziness, headache, and edema. However, these side effects are usually mild and transient.